Literature DB >> 16557162

Effects of epinephrine, norepinephrine, and phenylephrine on microcirculatory blood flow in the gastrointestinal tract in sepsis.

Vladimir Krejci1, Luzius B Hiltebrand, Gisli H Sigurdsson.   

Abstract

OBJECTIVE: The use of vasopressors for treatment of hypotension in sepsis may have adverse effects on microcirculatory blood flow in the gastrointestinal tract. The aim of this study was to measure the effects of three vasopressors, commonly used in clinical practice, on microcirculatory blood flow in multiple abdominal organs in sepsis.
DESIGN: Random order, cross-over design.
SETTING: University laboratory.
SUBJECTS: Eight sedated and mechanically ventilated pigs.
INTERVENTIONS: Pigs were exposed to fecal peritonitis-induced septic shock. Mesenteric artery flow was measured using ultrasound transit time flowmetry. Microcirculatory flow was measured in gastric, jejunal, and colon mucosa; jejunal muscularis; and pancreas, liver, and kidney using multiple-channel laser Doppler flowmetry. Each animal received a continuous intravenous infusion of epinephrine, norepinephrine, and phenylephrine in a dose increasing mean arterial pressure by 20%. The animals were allowed to recover for 60 mins after each drug before the next was started.
MEASUREMENTS AND MAIN RESULTS: During infusion of epinephrine (0.8 +/- 0.2 mug/kg/hr), mean arterial pressure increased from 66 +/- 5 to 83 +/- 5 mm Hg and cardiac index increased by 43 +/- 9%. Norepinephrine (0.7 +/- 0.3 mug/kg/hr) increased mean arterial pressure from 70 +/- 4 to 87 +/- 5 mm Hg and cardiac index by 41 +/- 8%. Both agents caused a significant reduction in superior mesenteric artery flow (11 +/- 4%, p < .05, and 26 +/- 6%, p < .01, respectively) and in microcirculatory blood flow in the jejunal mucosa (21 +/- 5%, p < .01, and 23 +/- 3%, p < .01, respectively) and in the pancreas (16 +/- 3%, p < .05, and 8 +/- 3%, not significant, respectively). Infusion of phenylephrine (3.1 +/- 1.0 mug/kg/min) increased mean arterial pressure from 69 +/- 5 to 85 +/- 6 mm Hg but had no effects on systemic, regional, or microcirculatory flow except for a 30% increase in jejunal muscularis flow (p < .01).
CONCLUSIONS: Administration of the vasopressors phenylephrine, epinephrine, and norepinephrine failed to increase microcirculatory blood flow in most abdominal organs despite increased perfusion pressure and-in the case of epinephrine and norepinephrine-increased systemic blood flow. In fact, norepinephrine and epinephrine appeared to divert blood flow away from the mesenteric circulation and decrease microcirculatory blood flow in the jejunal mucosa and pancreas. Phenylephrine, on the other hand, appeared to increase blood pressure without affecting quantitative blood flow or distribution of blood flow.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16557162     DOI: 10.1097/01.CCM.0000215834.48023.57

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  32 in total

Review 1.  Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes.

Authors:  Manuel Florian Struck; Peter Hilbert; Maja Mockenhaupt; Beate Reichelt; Michael Steen
Journal:  Intensive Care Med       Date:  2009-09-29       Impact factor: 17.440

Review 2.  Hypoxic hepatitis - epidemiology, pathophysiology and clinical management.

Authors:  Valentin Fuhrmann; Bernhard Jäger; Anna Zubkova; Andreas Drolz
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

3.  Sclerosing cholangitis in critically ill patients: an important and easily ignored problem based on a German experience.

Authors:  Ting Lin; Kai Qu; Xinsen Xu; Min Tian; Jie Gao; Chun Zhang; Ying Di; Yuelang Zhang; Chang Liu
Journal:  Front Med       Date:  2014-01-10       Impact factor: 4.592

4.  Impact of hypoxic hepatitis on mortality in the intensive care unit.

Authors:  Valentin Fuhrmann; Nikolaus Kneidinger; Harald Herkner; Gottfried Heinz; Mariam Nikfardjam; Anja Bojic; Peter Schellongowski; Bernhard Angermayr; Maximilian Schöniger-Hekele; Christian Madl; Peter Schenk
Journal:  Intensive Care Med       Date:  2011-06-07       Impact factor: 17.440

5.  Comparison of phenylephrine and norepinephrine in the management of dopamine-resistant septic shock.

Authors:  Gaurav Jain; D K Singh
Journal:  Indian J Crit Care Med       Date:  2010-01

Review 6.  Secondary Sclerosing Cholangitis in Critically Ill Patients: An Underdiagnosed Entity.

Authors:  Pedro Martins; Mariana Verdelho Machado
Journal:  GE Port J Gastroenterol       Date:  2019-07-30

Review 7.  Secondary sclerosing cholangitis.

Authors:  Petra Ruemmele; Ferdinand Hofstaedter; Cornelia M Gelbmann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

8.  Organ failure in sepsis.

Authors:  Herwig Gerlach; Susanne Toussaint
Journal:  Curr Infect Dis Rep       Date:  2007-09       Impact factor: 3.725

9.  Septic impairment of capillary blood flow requires nicotinamide adenine dinucleotide phosphate oxidase but not nitric oxide synthase and is rapidly reversed by ascorbate through an endothelial nitric oxide synthase-dependent mechanism.

Authors:  Karel Tyml; Fuyan Li; John X Wilson
Journal:  Crit Care Med       Date:  2008-08       Impact factor: 7.598

10.  Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial.

Authors:  Andrea Morelli; Christian Ertmer; Sebastian Rehberg; Matthias Lange; Alessandra Orecchioni; Amalia Laderchi; Alessandra Bachetoni; Mariadomenica D'Alessandro; Hugo Van Aken; Paolo Pietropaoli; Martin Westphal
Journal:  Crit Care       Date:  2008-11-18       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.